How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review

DSpace/Manakin Repository

How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review

Citable link to this page

 

 
Title: How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review
Author: Kramer, Daniel Bruce; Xu, Shuai; Kesselheim, Aaron Seth

Note: Order does not necessarily reflect citation order of authors.

Citation: Kramer, Daniel B., Shuai Xu, and Aaron S. Kesselheim. 2012. How does medical device regulation perform in the United States and the European Union? A systematic review. PLoS Medicine 9(7): e1001276.
Full Text & Related Files:
Abstract: Background: Policymakers and regulators in the United States (US) and the European Union (EU) are weighing reforms to their medical device approval and post-market surveillance systems. Data may be available that identify strengths and weakness of the approaches to medical device regulation in these settings. Methods and Findings: We performed a systematic review to find empirical studies evaluating medical device regulation in the US or EU. We searched Medline using two nested categories that included medical devices and glossary terms attributable to the US Food and Drug Administration and the EU, following PRISMA guidelines for systematic reviews. We supplemented this search with a review of the US Government Accountability Office online database for reports on US Food and Drug Administration device regulation, consultations with local experts in the field, manual reference mining of selected articles, and Google searches using the same key terms used in the Medline search. We found studies of premarket evaluation and timing (n = 9), studies of device recalls (n = 8), and surveys of device manufacturers (n = 3). These studies provide evidence of quality problems in pre-market submissions in the US, provide conflicting views of device safety based largely on recall data, and relay perceptions of some industry leaders from self-surveys. Conclusions: Few studies have quantitatively assessed medical device regulation in either the US or EU. Existing studies of US and EU device approval and post-market evaluation performance suggest that policy reforms are necessary for both systems, including improving classification of devices in the US and promoting transparency and post-market oversight in the EU. Assessment of regulatory performance in both settings is limited by lack of data on post-approval safety outcomes. Changes to these device approval and post-marketing systems must be accompanied by ongoing research to ensure that there is better assessment of what works in either setting.
Published Version: doi:10.1371/journal.pmed.1001276
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418047/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10471502
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters